Spleen Stiffness Measured by 2D-Shear Wave Elastography and Rebleeding Risk in Cirrhotic Patients Undergoing Endoscopic Variceal Ligation for Variceal Bleeding
Table 1
Baseline characteristics of the study population.
Characteristic
Value
Age (years)
(45-64)
Male
173 (85.6%)
Aetiology of cirrhosis (, %)
Alcohol
91 (45%)
BASH
40 (19.8%)
NASH
39 (19.3%)
HBV
23 (11.3%)
HCV
5 (2.5%)
Others
4 (2.1%)
Comorbidities
Diabetes mellitus
62 (50.8%)
Systemic hypertension
46 (37.7%)
Dyslipidaemia
14 (11.4%)
Child status
A
47 (23.3%)
B
72 (35.6%)
C
83 (41.1%)
MELD
(15-20)
Platelet count (lakh/mm3)
(0.7-1.2)
Albumin (mg/dL)
(2.5-3.3)
Hepatocellular carcinoma
16 (7.9%)
Compliance to treatment
141 (69.8%)
Post 2 weeks repeat EVL required
88 (43.6%)
3rd EVL required
20 (9.9%)
Pre-EVL SV (cm3)
(560.5-933.5)
Pre-EVL LS (kPa)
(23-35.8)
Pre-EVL SS (kPa)
(61-80.5)
Delta 1 VOL (cm3)
(-59.4-121.9)
Delta 1 SS (kPa)
(-12.1-4)
Delta 1 LS (kPa)
(-25-1.2)
Delta 2 VOL (cm3)
(-99.7-193.3)
Delta 2 LS (kPa)
2.6 ± 12.5 (1.1-7.4)
Delta 2 SS (kPa)
(6-15.4)
Delta 3 VOL (cm3)
(-242.3-231)
Delta 3 LS (kPa)
(6-17.4)
Delta 3 SS (kPa)
(10.2-24)
Patients with rebleeding at ≤6 months
45 (23.3%)
Patients who died at ≤6 months
41 (20.2%)
BASH: both alcoholic and nonalcoholic steatohepatitis; NASH: nonalcoholic steatohepatitis; HBV: hepatitis B virus; HCV: hepatitis C virus; MELD: model for end stage liver disease.
